DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

company name or ticker
Company Photos
(Click to zoom)

3 Biotechs Investors Should Watch

The healthcare version of Where the Money Is.

Incyte: Increasing Sales, Deep Pipeline, Multiple Catalysts, With A Side Of M&A Chatter

Unilife: A Medical Device Company Poised For Major Upside On New Revenue Streams

AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog

30 Nifty Fifty State Dividend Dogs Hound 13% September Upsides

AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug - Analyst Blog

How Will AstraZeneca (AZN) and Nektar Therapeutics (NKTR) Stock Reacy to FDA's Movantik Approval?

Update: AstraZeneca Announces Licensing Agreement

Drugs Stocks On The Rise With Help From 3 Stocks

COPD Occurs Most Often in These 5 States

COPD affects more than 6% of the U.S. population and costs $50 billion in direct and indirect costs annually, but these five states have the highest occurrence rate in the country.
See More Articles...